146 related articles for article (PubMed ID: 20146587)
1. Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.
Walbert T; Groves MD
Future Oncol; 2010 Feb; 6(2):287-97. PubMed ID: 20146587
[TBL] [Abstract][Full Text] [Related]
2. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
Lin Y; Li H; Huang M; Yin Z; Wu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
[TBL] [Abstract][Full Text] [Related]
3. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid-dissemination of a ovarian clear cell carcinoma: A leptomeningial carcinomatosis with diagnostic challenges.
Koyuncuer A; Varol E; Serarslan Yağcioğlu B; Bükte Y; Sakcı Z
Diagn Cytopathol; 2023 Aug; 51(8):E228-E231. PubMed ID: 37071049
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches to treating leptomeningeal metastases.
Grewal J; Saria MG; Kesari S
J Neurooncol; 2012 Jan; 106(2):225-34. PubMed ID: 21874597
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal metastasis from systemic cancer.
Clarke JL
Continuum (Minneap Minn); 2012 Apr; 18(2):328-42. PubMed ID: 22810130
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of leptomeningeal metastasis without a history of malignancy in the absence of cerebrospinal fluid abnormalities.
Yokote A; Kawamoto T; Namioka T; Moteki Y; Kawamata T
Clin Neurol Neurosurg; 2014 Apr; 119():88-90. PubMed ID: 24635933
[No Abstract] [Full Text] [Related]
8. Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis.
Ruotolo R; Maffei E; Sabbatino F; Serio B; Zeppa P; Caputo A
Diagn Cytopathol; 2023 Dec; 51(12):751-757. PubMed ID: 37638606
[TBL] [Abstract][Full Text] [Related]
9. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
Park IH; Kwon Y; Ro JY; Lee KS; Ro J
Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047
[TBL] [Abstract][Full Text] [Related]
10. Novel methods to diagnose leptomeningeal metastases in breast cancer.
Angus L; Martens JWM; van den Bent MJ; Sillevis Smitt PAE; Sleijfer S; Jager A
Neuro Oncol; 2019 Mar; 21(4):428-439. PubMed ID: 30418595
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
[TBL] [Abstract][Full Text] [Related]
12. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
[TBL] [Abstract][Full Text] [Related]
13. Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer.
Ju Y; Sun S; Wang J; Jiao S
J Cancer Res Ther; 2016 Oct; 12(Supplement):126-129. PubMed ID: 27721269
[TBL] [Abstract][Full Text] [Related]
14. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
[TBL] [Abstract][Full Text] [Related]
15. Intradural extramedullary spinal metastases of non-neurogenic origin: a distinct clinical entity or a subtype of leptomeningeal metastasis? A case-control study.
Knafo S; Pallud J; Le Rhun E; Parker F; Iakovlev G; Roux FX; Page P; Meder JF; Emery E; Devaux B;
Neurosurgery; 2013 Dec; 73(6):923-31; discussion 932. PubMed ID: 23921711
[TBL] [Abstract][Full Text] [Related]
16. Meningeal carcinomatosis as the first manifestation of malignant carcinomatosis.
Gdovinova Z; Feketeova E; Szilasiova J; Havlikova E; Banik P
Bratisl Lek Listy; 2009; 110(8):490-5. PubMed ID: 19750988
[TBL] [Abstract][Full Text] [Related]
17. [Advances in Diagnosis and Treatment of Leptomeningeal Metastasis of Lung Cancer].
Gao N; Xin T
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):517-523. PubMed ID: 35899451
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
Lin Y; Yu T; Li H; Yin Z; Guo A
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis.
Magbanua MJ; Melisko M; Roy R; Sosa EV; Hauranieh L; Kablanian A; Eisenbud LE; Ryazantsev A; Au A; Scott JH; Park JW
Cancer Res; 2013 Dec; 73(23):7134-43. PubMed ID: 24142343
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
